Dr. Paul Nguyen led a study looking at the link between certain prostate cancer treatments and heart-related deaths.
Steven Chang led a study showing robotic surgery for
prostate cancer may have led to changes in the number of surgeons performing
prostate removals and in the overall cost.
Paul L. Nguyen led a study showing prostate cancer patients with health
insurance are less likely to have metastatic disease or die from the
cancer than those without health insurance.
Dr. Mary-Ellen Taplin commented on a study showing that lung, liver, and other gut metastases are associated with the poorest survival in advanced hormone-refractory prostate cancer.
Tags: chemotherapy, ProstateCancer
Tags: BasicResearch, ProstateCancer
Tags: BasicResearch, BreastCancer, OvarianCancer, ProstateCancer, Genetics, GynecologicCancers
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: